πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

9,250 results for β€œIO” Clear

  1. Sivelestat sodium

    The First People's Hospital of Lianyungang

    Aortic Dissection

    small molecule active

    1 trial
  2. Siwu Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Brain Hypoperfusion Syndrome

    small molecule active

    1 trial
  3. Sniffing emotional tears

    Hospital Authority, Hong Kong

    Obesity

    mab completed

    1 trial
  4. Sodium Bicarbonate Ringer's Solution

    The First People's Hospital of Lianyungang

    Hyperlactacidemia

    small molecule active

    1 trial
  5. Specific Carbohydrate Diet

    NORTHWEST BIOTHERAPEUTICS INC

    Clostridium Difficile Infection

    other completed

    1 trial
  6. Spleen Invigorating and Weight Reducing Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Traditional Chinese Medicine Treatment

    small molecule active

    1 trial
  7. Split dose of 4L PEG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Health Behavior

    small molecule active

    1 trial
  8. Standard Care Arm

    United Therapeutics Europe Ltd

    Radiation Proctopathy

    small molecule completed

    1 trial
  9. Standard of Care medication for early Alzheimer's Disease

    BRIGHT MINDS BIOSCIENCES INC.

    Alzheimer Disease

    small molecule active

    1 trial
  10. Stereotactic body radiotherapy (SBRT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HSCT

    other active

    1 trial
  11. Study Agent

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    small molecule active

    1 trial
  12. Study product A (Wonderlab wonder4shape)

    Chongqing Precision Biotech Co., Ltd

    Overweight

    other completed

    1 trial
  13. Study product A (Wonderlab wonder4shape)

    Chongqing Precision Biotech Co., Ltd

    Overweight and Obesity

    other completed

    1 trial
  14. Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval

    Biotech Pharmaceutical Co.,

    Diphtheria

    mab completed

    1 trial
  15. Suanzaoren Decoction and Huanglian Wendan Decoction

    The First People's Hospital of Lianyungang

    Traditional Chinese Medicine

    small molecule active

    1 trial
  16. Super Cereal Plus (SC+)

    United Therapeutics Europe Ltd

    Moderate Acute Malnutrition (MAM)

    other terminated

    1 trial
  17. Supplementary Food

    United Therapeutics Europe Ltd

    Moderate Acute Malnutrition

    other completed

    1 trial
  18. Surgery combined with Target-reduction intensity-modulated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other active

    1 trial
  19. Surgery-radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    other active

    1 trial
  20. Symbiotic Formula with DHA and antioxidants

    Quantum Biopharma

    Cystic Fibrosis

    other completed

    1 trial
  21. Synbiotic

    United Therapeutics Europe Ltd

    Non-Alcoholic Fatty Liver Disease

    other completed

    1 trial
  22. Synovial Biopsy

    Lakefront Biotherapeutics NV

    Rheumatoid Arthritis

    other completed

    1 trial
  23. T cell injection targeting CD7 chimeric antigen receptor

    The First People's Hospital of Lianyungang

    T-ALL

    small molecule active

    1 trial
  24. T, 260 mg/m2, paclitaxel for injection (albumin-bound)

    The First People's Hospital of Lianyungang

    Breast Cancer

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources